The PROTECT (Pro-B Type Natriuretic Peptide Outpatient Tailored Chronic Heart Failure Therapy) study also demonstrated that NT-proBNP-guided HF management was associated with greater improvements in echocardiographic parameters of cardiac structure and function compared to standard care [77]. Here, NPPB is linked to hydrops fetalis.